Sang-Jun Ha Selected Research

CU06-1004

1/2020	CU06-1004-Induced Vascular Normalization Improves Immunotherapy by Modulating Tumor Microenvironment via Cytotoxic T Cells.
5/2014	Direct endothelial junction restoration results in significant tumor vascular normalization and metastasis inhibition in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sang-Jun Ha Research Topics

Disease

45	Neoplasms (Cancer) 05/2024 - 03/2005
18	Virus Diseases (Viral Diseases) 01/2023 - 06/2008
15	Infections 04/2023 - 07/2010
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2022 - 10/2012
9	Lung Neoplasms (Lung Cancer) 01/2023 - 04/2011
8	Persistent Infection 01/2021 - 10/2007
5	Tuberculosis (Tuberculoses) 04/2023 - 08/2006
3	Neoplasm Metastasis (Metastasis) 01/2018 - 03/2005
2	Pathologic Neovascularization 01/2023 - 11/2015
2	Inflammation (Inflammations) 01/2022 - 02/2015
2	Squamous Cell Carcinoma of Head and Neck 09/2021 - 11/2016
2	Viremia 08/2014 - 01/2013
2	Disease Progression 03/2013 - 02/2012
1	Pneumonia (Pneumonitis) 04/2023
1	Melanoma (Melanoma, Malignant) 02/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Gastritis 01/2021
1	Leukemia 01/2020
1	Fibrosis (Cirrhosis) 04/2019
1	Mucositis 01/2018
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 11/2016
1	Latent Tuberculosis 02/2015
1	Hypoxia (Hypoxemia) 05/2014
1	Lymphatic Metastasis 05/2014

Drug/Important Bio-Agent (IBA)

12	AntigensIBA 01/2023 - 03/2009
9	VaccinesIBA 04/2023 - 06/2008
9	LigandsIBA 11/2022 - 07/2010
7	CytokinesIBA 01/2023 - 07/2013
7	Immune Checkpoint InhibitorsIBA 02/2022 - 01/2020
5	ErbB Receptors (EGF Receptor)IBA 10/2021 - 04/2011
4	Interleukin-2 (IL2)IBA 04/2023 - 06/2008
4	B7-H1 AntigenIBA 09/2021 - 08/2011
4	RNA (Ribonucleic Acid)IBA 01/2021 - 10/2017
3	Immune Checkpoint ProteinsIBA 11/2022 - 01/2020
3	MucinsIBA 01/2021 - 08/2010
3	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 07/2012
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 05/2014
3	InterferonsIBA 01/2019 - 03/2005
3	Interleukin-6 (Interleukin 6)IBA 01/2017 - 01/2014
3	Antiviral Agents (Antivirals)IBA 01/2013 - 06/2008
3	Interleukin-12 (IL 12)IBA 11/2011 - 03/2005
2	Subunit VaccinesIBA 04/2023 - 08/2006
2	BCG Vaccine FDA Link 04/2023 - 11/2011
2	Interleukin-33IBA 01/2023 - 11/2020
2	Programmed Cell Death 1 ReceptorIBA 01/2023 - 01/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 04/2016
2	AntibodiesIBA 12/2021 - 08/2014
2	poliovirus receptorIBA 09/2021 - 01/2021
2	ChemokinesIBA 06/2021 - 04/2013
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2020
2	CU06-1004IBA 01/2020 - 05/2014
2	Cisplatin (Platino)FDA LinkGeneric 06/2016 - 05/2014
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 04/2016 - 01/2014
2	Interferon-gamma (Interferon, gamma)IBA 02/2015 - 01/2014
2	EpitopesIBA 08/2014 - 05/2009
2	Gefitinib (Iressa)FDA Link 03/2013 - 03/2012
2	Tyrosine Kinase InhibitorsIBA 10/2012 - 03/2012
2	DNA (Deoxyribonucleic Acid)IBA 11/2011 - 03/2005
2	Interleukin-10 (Interleukin 10)IBA 08/2010 - 12/2008
1	Verteporfin (Visudyne)FDA Link 05/2024
1	Angiogenesis InhibitorsIBA 01/2023
1	Cell-Penetrating PeptidesIBA 01/2023
1	platelet protein P47 (pleckstrin)IBA 01/2023
1	3-Phosphoinositide-Dependent Protein KinasesIBA 01/2023
1	AllergensIBA 01/2022
1	OvalbuminIBA 01/2022
1	AmphiregulinIBA 01/2022
1	Protein Subunit VaccinesIBA 10/2021
1	Cancer VaccinesIBA 10/2021
1	Chemokine CCL3IBA 06/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2020
1	Chemokine ReceptorsIBA 11/2020
1	3- (2- (2- tert- butylphenylaminooxalyl)aminopropionylamino)- 4- oxo- 5- (2,3,5,6- tetrafluorophenoxy)pentanoic acidIBA 01/2020
1	NivolumabIBA 01/2020
1	Apoptosis Regulatory ProteinsIBA 01/2020
1	birinapantIBA 01/2020
1	EnzymesIBA 08/2019
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 08/2019
1	HL156AIBA 04/2019
1	Metformin (Glucophage)FDA LinkGeneric 04/2019
1	Interferon Type IIBA 01/2019
1	Peptides (Polypeptides)IBA 01/2018
1	Methotrexate (Mexate)FDA LinkGeneric 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 04/2016
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2016
1	Oxygen (Dioxygen)IBA 11/2015
1	Interleukin-4 (Interleukin 4)IBA 10/2015
1	MitogensIBA 02/2015
1	Indicators and Reagents (Reagents)IBA 02/2015
1	N- alpha- benzoyl- N5- (2- chloro- 1- iminoethyl)- L- ornithine amideIBA 02/2015
1	Mycobacterium tuberculosis antigensIBA 02/2015

Therapy/Procedure

17	Immunotherapy 01/2023 - 03/2005
13	Therapeutics 01/2023 - 03/2005
2	Radiotherapy 04/2016 - 01/2014
1	Oral Administration 01/2023
1	Subcutaneous Injections 06/2021